BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Encision Announces Death of VP-Product Development Officer Michael Biggs

  Encision announced today that Michael Biggs, 48, its VP of Product Development died from injuries incurred from a bicycle accident.

  December 4, 2017

   · 

  2 min read
• Array BioPharma Announces Redemption of All Remaining 3.00% Convertible Senior Notes Due 2020

  The redemption will be made in accordance with the terms of the indenture governing the 2020 Notes and the terms of the redemption notice.

  December 4, 2017

   · 

  3 min read
• Drug Development

  Zynerba Pharmaceuticals Announces New ZYN002 Data From STAR 1 and STAR 2 Studies in Patients With Focal Seizures at the 2017 Annual Meeting of the American Epilepsy Society (AES)

  The key findings include that clinically meaningful responses to ZYN002, as measured by reductions in focal seizures from the baseline period of STAR 1, are correlated with continued treatment with ZYN002.

  December 4, 2017

   · 

  9 min read
• Policy

  Propanc Biopharma Advances Towards GMP Manufacture of PRP for Human Trials

  PRP is a solution for once-daily intravenous administration of a combination of two pancreatic proenzymes trypsinogen and chymotrypsinogen.

  December 4, 2017

   · 

  6 min read
• Led by OrbiMed Israel and Peter Thiel, ChemomAb Raises $10M in Series B Funding

  SBI Japan-Israel Innovation Fund and Milestone Venture also participated in the round.

  December 4, 2017

   · 

  3 min read
• Drug Development

  Spruce Biosciences Receives FDA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia

  Spruce Biosciences today announced that the FDA has granted orphan drug designation for SPR001 for the treatment of congenital adrenal hyperplasia.

  December 4, 2017

   · 

  2 min read
• Business

  BioStem Technologies Announces the Addition of University of Miami Professor Brant D. Watson, Ph.D., to the Company’s Scientific Advisory Board

  Dr. Watson’s research was funded by the National Institute of Neurological Diseases and Stroke for 22 years.

  December 4, 2017

   · 

  3 min read
• Drug Development

  Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program

  The study is sponsored by Therapix and led by Michael H. Bloch, M.D., Associate Professor at the Yale University Child Study Center, and James F. Leckman, M.D., Ph.D., Neison Harris Professor in the Child Study Center and Professor of Child Psychiatry at Yale University.

  December 4, 2017

   · 

  5 min read
• BD Announces New Offerings to Help Customers Deliver Safer, Simpler and Smarter Medication Management

  Exclusively at the BD booth, conference-goers will receive a comprehensive demonstration of the company’s enhanced solutions that are reinventing the entire medication management process, including

  December 4, 2017

   · 

  6 min read
• Policy

  Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA Ushering in New Era of 3D Printing of Medical Products; Provides Guidance to Manufacturers of Medical Devices

  Once considered a futuristic technology on the distant horizon, 3D printing of medical devices, medications and human tissue is quickly becoming a promising reality.

  December 4, 2017

   · 

  6 min read